Regarding your question about "proof of principle" as to why CYDY would pursue Leronlimab for Alzheimer's, take a look at the various studies and articles at the following Google link re: CCR5 and Alzheimer's (worth noting that Leronlimab is an incredibly safe CCR5 inhibitor that crosses the blood-brain barrier) --

Start here: https://www.google.com/search?q=ccr5+alzheimer's

Worth reading: https://www.nature.com/articles/s41586-022-04783-1

Worth watching (brief video): https://www.youtube.com/shorts/U46NQl1i-T0

I remain... #BULLISH